Literature DB >> 25380421

Takeda's second bet on DARTs.

.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25380421     DOI: 10.1038/nbt1114-1070a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Industry chases pan-genotypic and shorter HCV treatments.

Authors:  Anna Azvolinsky
Journal:  Nat Biotechnol       Date:  2015-06       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.